In an e-mail, a MM patient asked me where I was treated and if I would provide details. Well, sure.
I was treated at the University of Arkansas for Medical Sciences' Myeloma Institute for Research & Therapy (MIRT) in Little Rock, AR. http://myeloma.uams.edu/
The protocol that I followed was Total Therapy 4- Standard Arm. Dx- 11/25/08, IgG kappa, 77.5 % plasma cells at Dx (3% now!) , in Complete Remission. I'll share number progressions in later posts - when I'm convinced that people are actually reading this blog! : )
Total Therapy 4: Phase III Trial for Multiple Myeloma
11/24/08 Diagnosis IgG kappa
12/09/08 - Induction # 1
12/30/08 MVDTPACE
Stem Cell Collection - 24 Million
Velcade (days 1,5,8 and 11)
Melphalan (day 3)
DTPACE (days 5-8)
12/31/08 - Bridging
1/10/09 Dex / Thal
1/11/09 - Induction # 2
1/27/09 MVDTPACE
Velcade (days 1,4,8 and 11)
Melphalan (day 1)
DTPACE (days 1-4)
2/27/09 - Transplant # 1 (6 million stem cells)
3/17/09 Unfractionated Melphalan 200
Melphalan 200mg/m2 (day -1 )
Dexamethasone 40mg (days -2, -1, 0, and 1)
3/18/10- Bridging
4/12/10 Dex / Thal
(stop Thal. 7 days before Transplant)
4/13/09 Developed DVT
Hospitalized , Vena Cava Filter placed
Lovenox SQ prescribed for blood clots
5/13/09- Transplant # 2 (3 million stem cells)
5/29/09 Unfractionated Melphalan 200
Melphalan 200mg/m2 ( day -1 )(BSA Cap of 2.0)
Dexamethasone 40mg (days -2, -1, 0, and 1)
5/30/09- Bridging
7/13/09 Dex / Thal
7/14/09- Consolidation # 1
7/31/09 VDTPACE
Velcade (days 1,4,8 and 11)
DTPACE (days 1-4)
8/6/09 Kyphoplasty
(1) T-4
8/7/09- Bridging
9/3/09 Dex / Thal
9/4/09- Consolidation # 2
9/21/09 VDTPACE
Velcade (days 1,4,8 and 11)
DTPACE (days 1-4)
11/11/09- Maintenance
10/31/12 VRD (every 28 days x 3 years)
Velcade 1.9mg (days 1,8,15 and 22)
Dexamethasone 20mg (days 1,8,15 and 22)
Revlimid 15mg (days 1-21, off 22 – 28)
Zometa 4mg (every 3 months)
2/4/10 Kyphoplasty
(2) T 11-12
Drug Key:
V= Velcade
M= Melphalan
T = Thalidomide
D = Dexamethasone
P = Cisplatin
A = Adriamycin
C = Cyclophosphamide
E = Etoposide
G = Granulocyte Colony
Stimulating Factor
R = Revlimid,
What a year! All in all, I have fared well and feel pretty darn good. I still experience pain, neuropathy in my feet and hands, but I continue to progress. The treatment, as promised, was aggressively rough, but I'm still standing! Going to UAMS was a good decision for me.
graphic (c) UAMS/MIRT used with permission
